Beximco Pharmaceuticals Limited
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Beximco Pharmaceuticals Limited generated cash of $0, which is less than the previous year. Cash used in financing activities reached the amount of -$6,259,873,537 last year. Net change in cash is therefore -$281,580,529.
Cash Flow
| 2011 | 1.24B | -2.20B | 4.95M |
|---|---|---|---|
| 2012 | 0 | -1.58B | -235.59M |
| 2013 | 0 | -3.09B | 1.01B |
| 2014 | 0 | -2.27B | -314.75M |
| 2015 | 2.11B | -1.62B | -281.47M |
| 2018 | 1.81B | -6.62B | 4.90B |
| 2020 | 5.54B | -1.94B | -3.57B |
| 2021 | 6.02B | -2.52B | -3.45B |
| 2023 | 6.08B | -2.61B | -3.56B |
| 2024 | 0 | -2.40B | -6.25B |
BXP.L Cash Flow Statement (2011 – 2023)
| 2023 | 2022 | 2020 | 2019 | 2017 | 2015 | 2014 | 2013 | 2013 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.13B | 1.16B | 635.01M | 610.49M | 292.12M | 222.23M | 595.73M | 552.97M | 518.76M | 1.65B |
Operating activities | ||||||||||
Net income | 0 | 4.52B | 5.12B | 3.51B | 2.53B | 1.95B | 1.52B | 1.40B | 1.31B | 1.19B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 0 | 2.06B | 1.11B | 1.11B | 845.90M | 84.95M | 90.18M | 68.91M | 68.80M | 17.01M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | -431.83M | 431.60M | 29.50M | -566.04M | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | -1.82B | -1.08B | -70.13M | -1.21B | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 0 | 431.83M | 146.06M | -72.98M | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 0 | 6.08B | 6.02B | 5.54B | 1.81B | 2.11B | 0 | 0 | 0 | 1.24B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 106.92M | 0 | 0 | -339.78M | -493.17M | -1.33B |
Investments In Property Plant And Equipment | -1.99B | -2.41B | -2.55B | -2.27B | -5.05B | -2.56B | -2.83B | -2.76B | -1.09B | -1.20B |
Acquisitions Net | 0 | 0 | 0 | 0 | -2.12B | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -2.40B | -2.61B | -2.52B | -1.94B | -6.62B | -1.62B | -2.27B | -3.09B | -1.58B | -2.20B |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Payments for dividends | -1.58B | -1.56B | -578.35M | -601.95M | -502.75M | -367.89M | -350.85M | -47.58K | -340.50K | -126.95K |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | -4.67B | -1.76B | -504.63M | -1.00B | 1.85B | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | -6.25B | -3.56B | -3.45B | -3.57B | 4.90B | -281.47M | -314.75M | 1.01B | -235.59M | 4.95M |
Net Change In Cash | -281.58M | -32.98M | 40.45M | 24.52M | 101.61M | -74.76M | -373.49M | 42.75M | 34.21M | -952.64M |
Cash at end of period | 854.10M | 1.13B | 675.46M | 635.01M | 393.73M | 147.47M | 222.23M | 595.73M | 552.97M | 706.23M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |